Wellness Program Outreach and Effectiveness

Last updated: December 4, 2024
Sponsor: Massachusetts Institute of Technology
Overall Status: Active - Recruiting

Phase

N/A

Condition

High Cholesterol (Hyperlipidemia)

Metabolic Syndrome

Diabetes Prevention

Treatment

Opt-out framing

Opt-in framing

Clinical Study ID

NCT06725511
2402001204
  • Ages > 21
  • All Genders

Study Summary

The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellness and disease-management programs have the potential to improve wellbeing and reduce healthcare costs, their effectiveness is often undermined by low engagement and selection bias in participant comparisons. This study will test whether an outreach approach that auto-enrolls eligible individuals-employees and their spouses/domestic partners-into the program, with the option to opt out, can increase engagement and improve health outcomes compared to the standard invitation-based approach.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Provided informed consent.

  2. Those who are eligible for the Pack Health program:

  • Employees/spouses/domestic partners over the age of 18

  • Metabolic syndrome defined as results indicating 3 or more of the followingrisk factors:

  • High waist circumference (>35 inches for women and >40 inches for men)

  • High triglycerides (≥150 mg/dl)

  • Low HDL cholesterol (<50 mg/dl for women and <40 mg/dl for men)

  • High Blood Pressure (≥130/85)

  • High Fasting Glucose (≥100 mg/dl)

Exclusion

Exclusion Criteria:

  1. Anyone under the age of 21. They will not be part of the study and will receivemessages as if they were in the control group.

  2. Anyone observed in claims data with a historical diagnosis of:

  • Anorexia nervosa

  • Bulimia nervosa

  • Binge-eating disorder

  • Body dysmorphic disorder

  • Major depression

  • Post-traumatic stress disorder (PTSD)

  • Severe anxiety disorder

Study Design

Total Participants: 2000
Treatment Group(s): 2
Primary Treatment: Opt-out framing
Phase:
Study Start date:
October 02, 2024
Estimated Completion Date:
August 31, 2026

Study Description

The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellness and disease-management programs have the potential to improve wellbeing and reduce healthcare costs, their effectiveness is often undermined by low engagement and selection bias in participant comparisons. This study will test whether an outreach approach that auto-enrolls eligible individuals-employees and their spouses/domestic partners-into the program, with the option to opt out, can increase engagement and improve health outcomes compared to the standard invitation-based approach.

Participants will be randomly assigned to one of two groups: the intervention group, which will receive auto-enrollment outreach, and the control group, which will receive traditional invitation-based outreach. The primary outcome will measure program engagement as the share who begin the program. Secondary outcomes will include additional measures of engagement, such as the number of modules completed, health outcomes observed in subsequent risk assessments and healthcare claims, and employee retention. This trial will provide evidence on whether an opt-out framing in outreach campaigns can enhance the effectiveness of wellness programs, ultimately informing best practices for population health management.

Connect with a study center

  • Quest Diagnostics

    Secaucus, New Jersey 07094
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.